RU2019109719A - Конъюгаты полимиксин-альгинатных олигомеров - Google Patents

Конъюгаты полимиксин-альгинатных олигомеров Download PDF

Info

Publication number
RU2019109719A
RU2019109719A RU2019109719A RU2019109719A RU2019109719A RU 2019109719 A RU2019109719 A RU 2019109719A RU 2019109719 A RU2019109719 A RU 2019109719A RU 2019109719 A RU2019109719 A RU 2019109719A RU 2019109719 A RU2019109719 A RU 2019109719A
Authority
RU
Russia
Prior art keywords
polymyxin
alginate oligomer
oligomer conjugate
alginate
conjugate according
Prior art date
Application number
RU2019109719A
Other languages
English (en)
Russian (ru)
Other versions
RU2019109719A3 (cg-RX-API-DMAC7.html
Inventor
Элейн ФЕРГЮСОН
Дэвид Уильям ТОМАС
Арне ДЕССЕН
Филип РИЕ
Original Assignee
АльгиФарма АС
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1617860.0A external-priority patent/GB201617860D0/en
Priority claimed from GBGB1714710.9A external-priority patent/GB201714710D0/en
Application filed by АльгиФарма АС filed Critical АльгиФарма АС
Publication of RU2019109719A publication Critical patent/RU2019109719A/ru
Publication of RU2019109719A3 publication Critical patent/RU2019109719A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
RU2019109719A 2016-10-21 2017-10-20 Конъюгаты полимиксин-альгинатных олигомеров RU2019109719A (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1617860.0 2016-10-21
GBGB1617860.0A GB201617860D0 (en) 2016-10-21 2016-10-21 Polymyxin-alginate oligomer conjugates
GBGB1714710.9A GB201714710D0 (en) 2017-09-13 2017-09-13 Polymyxin-alginate oligomer conjugates
GB1714710.9 2017-09-13
PCT/EP2017/076927 WO2018073449A1 (en) 2016-10-21 2017-10-20 Polymyxin-alginate oligomer conjugates

Publications (2)

Publication Number Publication Date
RU2019109719A true RU2019109719A (ru) 2020-11-24
RU2019109719A3 RU2019109719A3 (cg-RX-API-DMAC7.html) 2021-02-20

Family

ID=60186268

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019109719A RU2019109719A (ru) 2016-10-21 2017-10-20 Конъюгаты полимиксин-альгинатных олигомеров

Country Status (13)

Country Link
US (1) US20190328833A1 (cg-RX-API-DMAC7.html)
EP (1) EP3528830B1 (cg-RX-API-DMAC7.html)
JP (1) JP2020503253A (cg-RX-API-DMAC7.html)
KR (1) KR20190072579A (cg-RX-API-DMAC7.html)
CN (1) CN109843315A (cg-RX-API-DMAC7.html)
AU (1) AU2017345295A1 (cg-RX-API-DMAC7.html)
BR (1) BR112019007927A2 (cg-RX-API-DMAC7.html)
CA (1) CA3040795A1 (cg-RX-API-DMAC7.html)
DK (1) DK3528830T3 (cg-RX-API-DMAC7.html)
ES (1) ES2933983T3 (cg-RX-API-DMAC7.html)
FI (1) FI3528830T3 (cg-RX-API-DMAC7.html)
RU (1) RU2019109719A (cg-RX-API-DMAC7.html)
WO (1) WO2018073449A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7683941B2 (ja) * 2019-12-14 2025-05-27 チャウダリ,マヌ 多臓器毒性を低減するための多塩基性薬剤の調製
WO2021150792A1 (en) * 2020-01-21 2021-07-29 Micurx Pharmaceuticals, Inc. Novel compounds and composition for targeted therapy of kidney-associated cancers
US12037631B2 (en) * 2020-10-06 2024-07-16 City University Of Hong Kong System and method for detecting a target enzyme
CN113081956A (zh) * 2021-04-12 2021-07-09 青岛大学附属医院 一种氧化海藻酸钠改性的那他霉素滴眼液及其制备方法
CN113069556B (zh) * 2021-04-12 2022-04-08 青岛大学附属医院 一种枝接那他霉素的氧化海藻酸纤维膜及其制备方法
WO2023001224A1 (en) * 2021-07-21 2023-01-26 Shanghai Micurx Pharmaceutical Co., Ltd. Novel compounds and compositions for targeted therapy of renal cancers
WO2023001223A1 (en) * 2021-07-21 2023-01-26 Shanghai Micurx Pharmaceutical Co., Ltd. Compounds and compositions for targeted therapy of renal diseases
CN114009731B (zh) * 2021-11-05 2024-01-02 恒枫食品科技有限公司 一种茶风味基料及其制备方法、应用
CN114752535A (zh) * 2022-05-16 2022-07-15 北京昊峰节能环保科技有限公司 一种总石油烃污染地下水生物修复剂及其制备方法与应用
CN121948713B (zh) * 2026-04-03 2026-07-17 亚太森博(山东)浆纸有限公司 一种硫酸盐法制浆中dcm控制剂引发二沉池浮泥的处理方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB976301A (en) * 1960-10-27 1964-11-25 Calmic Ltd Preparation and use of alginates
DE69012747T2 (de) * 1989-11-15 1995-03-16 Sandoz Ag Polymyxinkonjugate.
US5177059A (en) * 1989-11-15 1993-01-05 Sandoz Ltd. Polymyxin B conjugates
GB2270920B (en) * 1992-09-25 1997-04-02 Univ Keele Alginate-bioactive agent conjugates
US6011008A (en) * 1997-01-08 2000-01-04 Yissum Research Developement Company Of The Hebrew University Of Jerusalem Conjugates of biologically active substances
RU2527894C2 (ru) * 2007-11-27 2014-09-10 Альгифарма ИПР АС Использование альгинатных олигомеров в борьбе с биопленками
RU2582938C2 (ru) * 2009-06-03 2016-04-27 АльгиФарма АС Альгинатные олигомеры для применения в преодолении множественной лекарственной устойчивости у бактерий

Also Published As

Publication number Publication date
WO2018073449A1 (en) 2018-04-26
CA3040795A1 (en) 2018-04-26
EP3528830A1 (en) 2019-08-28
RU2019109719A3 (cg-RX-API-DMAC7.html) 2021-02-20
FI3528830T3 (fi) 2023-01-13
KR20190072579A (ko) 2019-06-25
EP3528830B1 (en) 2022-10-05
JP2020503253A (ja) 2020-01-30
AU2017345295A1 (en) 2019-05-02
CN109843315A (zh) 2019-06-04
ES2933983T3 (es) 2023-02-15
DK3528830T3 (da) 2022-12-19
BR112019007927A2 (pt) 2019-07-02
US20190328833A1 (en) 2019-10-31

Similar Documents

Publication Publication Date Title
RU2019109728A (ru) Конъюгаты бацитрацин-альгинатный олигомер
FI3528830T3 (fi) Polymyksiini-alginaattioligomeerikonjugaatteja
JP2020503253A5 (cg-RX-API-DMAC7.html)
JP2019535669A5 (cg-RX-API-DMAC7.html)
CN102688498B (zh) 紫杉烷类药物-羧甲基壳聚糖两亲性大分子前药、胶束制剂和冻干胶束制剂,及其制备方法
EP2641605B1 (en) Polymer derivative of cytidine metabolism antagonist
KR20120057588A (ko) 가변 속도 방출 링커를 포함하는 폴리알 약물 접합체
JP2019526537A5 (cg-RX-API-DMAC7.html)
CN104109235A (zh) 一种具有氮原子支化中心的单一官能化聚乙二醇、制备方法及其生物相关物质
JP2011006428A5 (cg-RX-API-DMAC7.html)
MXPA04011316A (es) Derivados de camptotecina y conjugados polimericos de los mismos.
AU2007332031A1 (en) Thiol-Modified Macromolecule Derivatives and Cross-Linked Materials Thereof
EP3288955B1 (en) Bortezomib-based delivery system
WO2007111211A1 (ja) タキサン類の高分子結合体
TW200936153A (en) Short fatty acid tail polymyxin derivatives and uses thereof
CN101780281B (zh) N-精氨酸壳聚糖作为透皮吸收促进剂的应用
CN1203071C (zh) 谷氨酸n-衍生物的多糖酯
WO2013110681A1 (en) Chitosan covalently linked with small molecule integrin antagonist for targeted delivery
CN106589391A (zh) 壳聚糖/聚赖氨酸树状大分子核壳纳米粒及其制备方法
JP2010533233A (ja) 芳香族アリル酸を含むポリマー性薬剤送達システム
JP6360243B1 (ja) エモジンを担持するためのナノ粒子の新規な調製方法
CN101066460A (zh) 季胺盐改性的壳聚糖亲核no供体的合成方法
CN107108761B (zh) 硫酸软骨素衍生物和膀胱疾病处置剂
CN105492494B (zh) 聚氨基酸的制造方法
CN106986955B (zh) 一种肝素的叠氮化修饰方法和叠氮化肝素及应用